Painfully Obvious: Expanding Inpatient Buprenorphine for Opioid Use Disorder

Authors

Aline Levy-Sitnoveter, HCA Healthcare
Mark Delic, HCA HealthcareFollow
Jonathan Aires Pinheiro, HCA HealthcareFollow
Eleana Estrella, HCA HealthcareFollow
Sankalp Goberdhan, HCA HealthcareFollow
Lauren Hundley, Orlando VA Healthcare System
Richard Henriquez, HCA Healthcare
Shamol Williams, Orlando VA Healthcare System

Files

Division

North Florida

Hospital

HCA Florida Osceola Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2025

Keywords

Opioid Use Disorder, Buprenorphine

Disciplines

Chemicals and Drugs | Internal Medicine | Medicine and Health Sciences | Quality Improvement

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Levy-Sitnoveter, Aline; Delic, Mark; Aires Pinheiro, Jonathan; Estrella, Eleana; Goberdhan, Sankalp; Hundley, Lauren; Henriquez, Richard; and Williams, Shamol, "Painfully Obvious: Expanding Inpatient Buprenorphine for Opioid Use Disorder" (2025). North Florida Division GME Research Day 2025. 25.
https://scholarlycommons.hcahealthcare.com/northflorida2025/25